Possible Tissue Glucocorticoid Hypersensitivity in Human Immunodeficiency Virus type-1 (HIV-1) Infection

References

• 1 Kino T, Chrousos G P. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes.  J Endocrinol. 2001;  169 437-445
• 2 Kino T, Chrousos G P. Acquired immunodeficiency syndrome-related insulin resistance and lipodystrophy: a multifactorial viral and iatrogenic condition.  Endocr Pract. 2001;  7 480-484
• 3 Kino T, Gragerov A, Kopp J B, Stauber R H, Pavlakis G N, Chrousos G P. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor.  J Exp Med. 1999;  189 51-62
• 4 Kino T, Gragerov A, Slobodskaya O, Tsopanomichalou M, Chrousos G P, Pavlakis G N. Human immunodeficiency virus type-1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators.  J Virol. 2002;  76 9724-9734
• 5 Mirani M, Elenkov I, Volpi S, Hiroi N, Chrousos G P, Kino T. HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection.  J Immunol. 2002;  169 6361-6368
• 6 Kino T, Slobodskaya O, Pavlakis G N, Chrousos G P. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex.  J Biol Chem. 2002;  277 2396-2405